Understanding Long-Term Survival in ALS: A Cohort Study on Subject Characteristics and Prognostic Factors

Area of Science:

• Neurology
• Neurodegenerative Diseases
• Epidemiology

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder with highly variable patient survival.
• While most individuals with ALS survive 2-4 years, a significant minority (5-15%) experience longer prognoses.

Purpose of the Study:

• To investigate the clinical characteristics of long-term survivors (≥10 years) of Amyotrophic Lateral Sclerosis (ALS).
• To identify factors associated with extended survival in a population-based ALS cohort.

Main Methods:

• Retrospective, observational study utilizing a population-based ALS registry in Lombardy, Italy.
• Inclusion of incident ALS cases from two distinct time periods (1998-2002 and 2008-2012).
• Analysis of clinical data to compare long-term survivors (≥10 years) with non-long-survivors.

Main Results:

• The overall cohort of 828 ALS cases had a median survival of 2.2 years.
• Long-term survival (≥10 years) was observed in 7% of patients, with 3% surviving 15 years.
• Long-survivors were characterized by younger age at onset/diagnosis, longer diagnostic delay, spinal onset, and a higher proportion of males.
• No significant difference in survival rates was found between the two study periods.

Conclusions:

• Long-term survival in ALS is influenced by a multifactorial interplay of clinical, genetic, and environmental factors.
• The intrinsic rate of motor neuron degeneration appears to be a key determinant in ALS progression and survival.
• Further research into these factors is crucial for understanding and potentially improving outcomes for ALS patients.